Léim ar aghaidh chuig an bpríomhábhar
Gnáthamharc

Medicinal Products

Dáil Éireann Debate, Wednesday - 15 February 2023

Wednesday, 15 February 2023

Ceisteanna (167, 172)

Duncan Smith

Ceist:

167. Deputy Duncan Smith asked the Minister for Health the number of cariban prescriptions which have been processed through the drug payment scheme to date; and if he will make a statement on the matter. [7493/23]

Amharc ar fhreagra

Marian Harkin

Ceist:

172. Deputy Marian Harkin asked the Minister for Health to release the number of cariban prescriptions that have been processed through the drugs payment scheme for the years 2019, 2020, 2021 and 2022, in tabular form. [7564/23]

Amharc ar fhreagra

Freagraí scríofa

I propose to take Questions Nos. 167 and 172 together.

Following the recommendations of the HSE Medicines Management Programme, and to help women who experience hyperemesis gravidarum (a severe form of nausea and vomiting during pregnancy), since 1st January 2023, reimbursement support for Cariban® (doxylamine/pyridoxine) has been made available under an exceptional arrangement on an individual patient basis where consultant initiated. Hyperemesis gravidarum is expected to affect about 1% of the pregnant population.

There were no applications under this arrangement for the years 2019, 2020, 2021 or 2022.

As of 10th February 2023, the number of applications received by the HSE Primary Care Reimbursement Service (PCRS) stands at 384. The number of applications to date is in line with expectations.

Barr
Roinn